KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Prepaid Assets (2017 - 2025)

Amneal Pharmaceuticals has reported Prepaid Assets over the past 9 years, most recently at $98.4 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $98.4 million for Q4 2025, up 21.9% from a year ago — trailing twelve months through Dec 2025 was $98.4 million (up 21.9% YoY), and the annual figure for FY2025 was $98.4 million, up 21.9%.
  • Prepaid Assets for Q4 2025 was $98.4 million at Amneal Pharmaceuticals, down from $101.5 million in the prior quarter.
  • Over the last five years, Prepaid Assets for AMRX hit a ceiling of $232.2 million in Q2 2022 and a floor of $75.1 million in Q1 2021.
  • Median Prepaid Assets over the past 5 years was $90.0 million (2023), compared with a mean of $102.4 million.
  • Biggest five-year swings in Prepaid Assets: soared 123.71% in 2022 and later tumbled 64.79% in 2023.
  • Amneal Pharmaceuticals' Prepaid Assets stood at $110.2 million in 2021, then fell by 6.04% to $103.6 million in 2022, then dropped by 20.16% to $82.7 million in 2023, then decreased by 2.38% to $80.7 million in 2024, then rose by 21.9% to $98.4 million in 2025.
  • The last three reported values for Prepaid Assets were $98.4 million (Q4 2025), $101.5 million (Q3 2025), and $85.3 million (Q2 2025) per Business Quant data.